Skip to Content

Jeffrey H. Lee, MD, MPH, FASGE, FACG

Present Title & Affiliation

Primary Appointment

Professor, Department of Gastroenterology, Hepat,& Nutr, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Director, Advanced Therapeutic Endoscopy Fellowship, Department of Gastroenterology, Hepat,& Nutr, The University of Texas MD Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd
Unit Number: 1466
Houston, TX 77030
Phone: 713-794-5073
Fax: 713-563-4408

Education & Training

Postgraduate Training

1998-1999 Clinical Fellowship, Advanced Therapeutic Endoscopy, Harvard Medical School, Brigham and Women's Hospital, Boston, MA

Board Certifications

1998 American Board of Internal Medicine, Gastroenterology, Recertification Date: 2008

Selected Publications

Peer-Reviewed Original Research Articles

1. Neishboori N, Wadhwa R, Nogueras-Gonzalez G, Elimova E, Shiozaki H, Sudo K, Charalampakis N, Hiremath A, Lee J, Bhutani M, Weston B, Blum M, Rogers J, Garris J, Rice D, Komaki R, Swisher S, Skinner H, Hofstetter W, Ajani J. Distributiion of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical Implications. Oncology 89(2):65-9, 3/2015.
2. Shiozaki H, Slack R, Sudo K, Elimova E, Wadhwa R, Chen HC, SKinner HD, Komaki R, Lee JH, Weston B, Bhutani MS, Blum MA, Rogers JE, Maru DM, Hofstetter WL, Ajani JA. Geographic Distribution of Regional Metastatic Nodes Affects the Outcome of Trimodality-Eligible Patients with Esophageal Adenocarcinoma. Oncology 88(6). e-Pub 2/2015.
3. Skinner HD, Lee JH, Bhutani MS, Weston B, Hofstetter W, Komaki R, Shiozaki H, Wadhwa R, Sudo K, Elimova EE, Song S, Ye Y, Huang M, AJani J, Wu X. A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma. Cancer, 8/2014.
4. Taketa T, Sudo K, Correa AM, Wadhwa R, Shiozaki H, Elimova E. Campagna MC, Blum MA, Skinner HD, Komaki RU, Lee JH, Bhutani MS, Weston BR, Rice DC, Swisher SG, Maru DM, Hofstetter WL, Ajani JA. Post-chemoradiation surgical pathology stage can customize the surveillance strategy in patients with esophageal adenocarcinoma. J Natl Compr Canc Netw 12(8):1139-44, 8/2014.
5. Song S, Ajani JA, Honjo S, Maru DM, Ailing S, Heallen TR, Xiao L, Hofstetter WL, Weston B, Lee JH, Wadhwa R, Sudo Kazuki, Yao Y, Martin J, Hung MC, Johnson RL. The Hippo Coactivator YAP1 Upregulates SOX9 and Endows Cancer Stem Cell Properties in non-tumorigenetic cells and esophageal cancer cells. Cancer Res 74(15):4170-82, 8/2014. e-Pub 6/2014.
6. Shiozaki H, Sudo K, Xiao L, Wadhwa R, Elimova E, Hofstetter WL, Skinner HD, Lee JH, Weston B, Bhutani MS, Maru DM, Blum MA, Ajani JA. Distribution and timing of distant metastasis after local therapy of patients with esophageal and esophagogastric junction cancer. Oncology 86((5-6)):336-339, 6/2014.
7. Krishna SG, Rao BB, Lee JH. Endoscopic sonography and sonographically guided fine-needle aspiration biopsy in the diagnosis of unusual pancreatic metastases from synovial sarcoma. J Clin Ultrasound 42(3):180-2, 3/2014. e-Pub 9/2013.
8. Ajani JA, Wang X, Song S, Sudo K, Wadhwa R, Hofstetter WL, Komak R, Dipen M, Lee JH, Bhutani M, Weston B, Baladandayuthapani V, Yao Y, Skinner H, Johnson RL, Berry D. ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients. Molecular Oncology 8(1):142-9, 2/2014. e-Pub 10/2013.
9. Sudo K, Taketa T, Correa AM, Cahmpagna MC, Wadhwa R, Blum MA, Komaki R, Lee JH, Bhutani MS, Weston B, SKinner HD, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Locoregional failure rate after preoperative chemoradation of esophageal adenocarcinoma and the outcomes of salvage strategies. J Clin Oncol 31(34):4306-10, 12/2013. PMCID: PMC3837091.
10. Ajani JA, Xiao L, Roth JA, Hofstetter WL, Walsh GL, Komaki R, Liao Z, Rice DC, Vaporciyan AA, Dipen MM, Lee JH, Bhutani M, Eid A, Yao JC, Phan A, Halpin AK, Akihiro S, Taketa T, Thall PF, Swisher SG. A Phase 2 Randomized Trial of Induction Chemotherapy versus no induction Chemotherapy followed by preoperative chemoradiation in patients wiht esophageal cancer. Journal of Clinical Oncology 24(11):2844-9, 11/2013. e-Pub 8/2013. PMCID: PMC3937600.
11. Suzuki A, Xiao L, Taketa T, Sudo K, Wadhwa R, Blum MA, Skinner H, Komaki R, Weston B, Lee JH, Bhutani MS, Rice DC, Maru DM, Erasmu J, Swisher SG, Hofstetter WL, Ajani JA. Results of the baseline positron emission tomography can customize therapy of localized esophageal adenocarcinoma in Patients who achieve a clinical complete response after chemoradiation. Annals of Oncology 24(1):2854-9, 11/2013. e-Pub 8/2013.
12. Wadhwa R, Taketa T, Correa A, Sudo K, Campagna MC, Blum Murphy M, Komaki R, Skinner H, Lee JH, Bhutani M, Weston B, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Incidence of Brain Metastases after Trimodality Therapy in Patients with Esophageal or Gastroesophageal Cancer: Implications for Screening and Surveillance. Oncology 85(4):204-207, 9/2013.
13. Francis AM, Sepesi B, Correa AM, Blum MA, Erasmus JJ, Lee JH, Maru DM, Mehra RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Welsh JW, Swisher SG, Hofstetter WL. The influence of histopathologic tumor viability on Long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinoma. Ann Surg 258(3):500-7, 9/2013.
14. Taketa T, Xiao L, Suzuki A, Wadhwa R, Blum M, Lee JH, Weston B, Bhutani M, Skinner H, Komaki R, Maru D, Rice D, Swisher S, Hofstetter W, Ajani JA. Propensity-based Matching between Esophagogastric Cancer Patients Who Had Surgery and Who Declined Surgery after Preoperative Chemoradiation. Oncology 85(2):95-99, 7/2013.
15. Kochar R, Atiq M, Lee JH, Landon G, Mansfield PF,Bhutani MS. Giant Hepatic Hemangioma masquerading as a gastric subepithelial tumor. Gastroenterol Hepatol 9(6):396-8, 6/2013. PMCID: PMC3736798.
16. Suzuki R, Lee JH, Krishna SG, Ramireddy S, Qiao W, Weston B, Ross WA, Bhutani MS. Repeat endoscopic ultrasound-guided fine needle aspiration biopsy (EUS-FNA) for solid pancreatic lesions will alternate the initial inconclusive result. J Gastrointestin Liver Dis 22(2):183-187, 6/2013.
17. Cheedella NK, Suzuki A, Xiao L, Hofstetter WL, Maru DM, Takta T, Sudo K, Blum MA, Lin SH, Welch J, Lee JH, Bhutani MS, Rice DC, Vaporciyan AA, Swisher SG, Ajani JA. Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: Analysis in a large cohort. Ann Oncol 24(5):1262-6, 5/2013. e-Pub 12/2012. PMCID: PMC3629896.
18. Atiq M, Suzuki R, Khan AS, Krishna SG, Ridgway TM, Guha S, Hernandez LV, Nealon WH, Lee JH, Bhutani MS. Clinical decision making in the management of pancreatic cystic neoplasms. Expert Rev Gastroenterolo Hepatol 7(4):353-60, 5/2013.
19. Atiq M, Bhutani MS, Ross WA, Raju GS, Gong Y, Tamm EP, Javle M, Wang X, Lee JH. Role of Endoscopic Ultrasound in Evaluation of Metastatic Lesions to the Pancreas: A tertiary cancer center experience. Pancreas 42(3):516-23, 4/2013. e-Pub 12/2012.
20. Lee JH, Krishna SG, SinghA, Ladha HS, Slack RS, Ramireddy S, Raju GS, Davila M, Ross WA. Comparison of the utility of covered metal stents versus uncovered metal stents in the management of malignant biliary strictures in 749 patients. Gastrointest Endosc 78(2):312-24, 2013.
21. Wang W, Shpaner A, Krishna SG, Ross WA, Bhutani MS, Tamm EP, Raju GS, Xiao L, Wolff RA, FLeming JB, Lee JH. Use of EUS-FNA in diagnosing pancreatic neoplasm without a definitive mass on CT. Gastrointest Endosc 78(1):73-80, 2013.
22. Hayashi Y, Xiao L, Suzuki A, Blum MA, Sabloff B, Taketa T, Maru DM, Welsh J, Lin SH, Weston B, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Ajani JA. A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer. Eur J Cancer 48(18):3396-404, 12/2012.
23. Singh A and Lee JH. Self-expanding metal stents for preoperative biliary drainage in patients receiving neoadjuvant therapy for pancreatic cancer. Journ of Gastrointest Oncology 3(4):304-5, 12/2012. PMCID: PMC3492472.
24. Murphy MA, Taketa T, Sudo K, Lee JH, Ajani JA. Surveillance for esophageal cancer: does it make sense? J Natl Compr Canc Netw 10(12):1590-2, 12/2012.
25. Canto MI, Harinck F, Hruban RH, Offerhaus GJ, Poley JW, Kamel I, Nio Y, Schulick RS, Bassi C, Kluijt I, Levy MJ, Chak A, Fockens P, Goggins M, Bruno M; International Cancer of the Pancreas Screening (CAPS) Consortium. International Cancer of the Pancreas Screening (CAPS) Consortium Summit on the Managment of Patients with Increased Risk for Familial Pancreatic Cancer. Gut. e-Pub 11/2012.
26. Kanda M, Sadakri Y, Borges M, Topazian M, Farrell J, Syngal S, Lee J, Kamel I, Lennon AM, Knight S, Fujiwar S, Hruban RH, Canto MI, Goggins M. Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia. Clinical Gastroenterology and Hepatology S1542-3565(12):1413-9, 11/2012.
27. Ajani AJ, Correa AM, Hofstetter WL, Rice DC, Blum MA, Suzuki A, Taketa T, Welsh J, Lin SH, Lee JH, Bhutani MS, Ross WA, Maru M, Macapinlac HA, Erasmus J, Komaki R, Mehran RJ, Vaporciyan AA, Swisher SG. Clinical Parameters Model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer. Ann Oncol 23(10):2638-42, 10/2012. e-Pub 7/2012.
28. Marks JL, Hofstetter W, Correa AM, Mehran RJ, Rice D, Roth J, Walsh G, Vaporciyan A, Erasmus J, Change J, Maru D, Lee JH, Ajani JA, Swisher SG. Salvage esophagectomy after failed definitive chemoradiation for esophageal adenocarcinoma. Ann Thorac Surg 94(4):1126-32, 10/2012. e-Pub 8/2012.
29. Taketa T, Correa AM, Suzuki A, Blum MA, Chien P, Lee JH, Welsh J, Lin SH, Maru DM, Erasmus JJ, Bhutani MS, Weston B, Ross WA, Rice DC, Vaporciyan AA, Swisher SG, Hofstetter WL, Ajani JA. Outcome of Trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiation. Oncology 83(5):300-4, 9/2012.
30. Kanda M, Knight S, Topazian MD, Syngal S, Farrell J, Lee JH, Kamel I, Lennon AM, Borges M, Young A, Fujiwara S, Seike J, Eshleman J, Hruban RH, Canto M, Goggins. Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts. Gut, 8/2012. e-Pub 8/2012.
31. Saftoui A, Bhutani MS, Vilmann P, Surlin V, Uthamanthil RK, Lee JH, Bektas M, Singh H, Ghenonea DI, Patrascu S, Gupta V, Katz MH, Fleming JB. Feasibility study of EUS-NOTES as a novel approach for pancreatic cancer staging and therapy: an international collaborative study. Hepatogastroenterology 6(60):121, 7/2012.
32. Tamm EP, Balachandran A, Bhosale PR, Katz MH, Fleming JB, Lee JH, Varadhachary GR. Imaging of pancreatic adenocarcinoma: update on staging/resectability. Radiol Clin North Am 50(3):407-28, 5/2012. e-Pub 4/2012.
33. Canto MI, Hruban RR, Fishman EK, Kamel IR, Schulick R, Zhang A, Topazian M, Takahashi N, Fltcher J, Petersen G, Klein AP, Axilbund J, Griffin C, Syngal S, Saltzman JR, Mortele KJ, Lee JH, Tamm E, VIkram R, Bhosale P, Margolis D, Farrell J, Goggins M. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 142(4):796-804, 4/2012.
34. Kountourakis P, Ajani JA, Davila M, Lee JH, Bhutani MS, Izzo JG. Barrett's esophagus: a Review of biology and therapeutic approaches. Gastrointest Cancer Res 5(2):49-57, 3/2012.
35. Atiq M, Gong Y, Raju GS, Lee JH. Pancreatic Endocrine Microadenomatosis in a patient with oculofaciocardiodental (OFCD) syndrome. Pancreas 41(2):327-9, 3/2012. PMID: 22343980.
36. Thosani N, Singh H, Kapadia A, Ochi N, Lee JH, Ajani J, Swisher SG, Hofstetter WL, Guha S, Bhutani MS. Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers; a systematic review and meta-analysis. Gastrointest Endosc 75(2):242-53, 2/2012. e-Pub 11/2011.
37. Suzuki A, Xiao L, Hayashi Y, Blum MA, Welsh JW, Lin SH, Lee JH, Bhutani MS, Weston B, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Erasmus J, AJani JA. Nomograms for prognostication of outcome in patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapy. Oncology 82(2):108-113, 2/2012. PMID: 22328056.
38. Canto MI, Hruban RH, Fishman EK, Kamel IR, Schulick R, Zhang Z, Topazian M, Takahashi N, Fletcher J, Petersen G, Klein AP, Axilbund J, Griffin C, Syngal S, Saltzman JR, Mortele KJ, Lee JH, Tamm E, Vikram R, Bhosale P, Margolis D, Farrell J, Goggins M. American Cancer of the Pancreas screening (CAPS) consortium, frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 142(4):796-804, 2012. PMCID: PMC3321068.
39. Amini A, Xiao L, Allen PK, Suzuki A, Hayashi Y, Liao Z, Hofstetter W, Crane C, Komaki R, Bhutani MS, Lee JH, Ajani JA, Welsh H. Celiac Node Failure Patterns after definitive chemoradiation for esophageal cancer in the modern era. Int J Radiat Oncol Biol Phys 83(2):e231-9, 2012. e-Pub 3/2012. PMCID: PMC3795392.
40. Lee JH, Singh A. Difficult endoscopic retrograde cholangiopancreatography in cancer patients. Gastrointest interv 1:19-24, 2012.
41. Jaganmohan S, Lynch PM, Raju RM, Ross WA, Lee JE, Raju GS, Bhutani MS, Fleming JB, Lee JH. Endoscopic management of duodenal adenomas in familial adenomatous polyposis- A single center experience. Dig Dis Sci 57(3):732-7, 2012. e-Pub 9/2011.
42. Atiq M, Bhutani MS, Bektas M, Lee JE, Gong Y, Tamm EP, Shah CP, Ross WA, Yao J, Raju GS, Wang X, Lee JH. EUS-FNA pancreatic neuroendocrine Tumors: A tertiary cancer center experience. Dig Dis Sci 57(3):791-800, 2012. e-Pub 10/2011.
43. Suzuki A, Xiao L, Taketa T, Blum MA, Matamoros A Jr, Chien PL, Mansfield PF, Fournier KF, Weston B, Lee JH, Bhutani MS, Estrella JS, Delclos ME, Krishnan S, Das P, Ajani JA. Localized gastric cancer treated with chemoradion without surgery: UTMD Anderson Cancer Center experience. Oncology 82(6):347-51, 2012.
44. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Mehran RJ, Rice DC, Suzuki A, Lee JH, Bhutani MS, Welsh J, Lin SH, Maru DM, Swisher SG, Ajani JA. Patients with high body mass index tend to have lower stage of esophageal carcinoma at diagnosis. Dis Esophagus 25(7):614-22, 2012.
45. Jaganmohan S, Lee JH. Self-expandable metal stents in malignant biliary obstruction. Expert Review. Gastroenterology & Hepatology 6(1):105-14, 2012.
46. Singal AK, Ross WA, Guturu P, Varadhachary G, Javle M, Jaganmohan S, Raju R, Fleming J, Raju GS, Kuo YF, Lee JH. Self-expanding metal stents for biliary drainage in patients with resectable pancreatic cancer: Single-center experience with 79 cases. Dig Dis and Sci 56(12):3678-84, 12/2011. e-Pub 7/2011.
47. Suzuki A, Xiao L, Hayashi Y, Macapinlac HA, Welsh J, Lin SH, Lee JH, Bhutani MS, Maru DM, Hofstetter WL, Swisher SG, Ajani JA. Prognostic significance of baseline positron emission tonography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy. Cancer 117(21):4823-33, 11/2011. e-Pub 3/2011.
48. Krishna S, Lee JH. Endosonographpy in solid and cystic pancreatic tumors. Journal of Interventional Gastroenterology 1(4):193-201, 10/2011. PMCID: PMC3350895.
49. Atiq M, Bhutani MS, Bektas M, Lee JE, Gong Y, Tamm EP, Shah CP, Ross WA, Yao J, Raju GS, Wang X, Lee JH. EUS-FNA for pancreatic neuroendocrine tumors: a tertiary cancer center experience. Dig Dis Sci 57(3):791-800, 10/2011.
50. Ioncica AM, Atiq M, Lee JH, Saftoiu A, Bhutani MS. Gastric and pancreatic metastases from pleomorphic lung carcinoma. Endoscopy 43(Suppl 2):E317-8, 10/2011. e-Pub 10/2011.
51. Kim HN, Alouis AM, Lee JH, Qiao W, Xiao L, Ross WA. Role of ERCP in patients after hematopoietic stem cell transplantation. Gastrointest Endosc 74(4):817-24, 10/2011. e-Pub 7/2011.
52. Estrella JS, Hofstetter WL, Correa A, Swisher SG, Ajani JA, Lee JH, Bhutani M, Abraham S, Rashid A. Duplicated muscularis mucosa invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma. Am journ of surg path 35(7):1045-53, 7/2011.
53. Raju RP, Jaganmohan SR, Ross WA, Davila M, Javle M, Raju GS, Lee JH. Optimal palliation of inoperable hilar cholangiocarcinoma: Comparative assessment of the efficacy of plastic and self-expanding metal stents. Dig Dis and Sci 56(5):1557-64, 5/2011. e-Pub 1/2011. PMID: 212221566.
54. Kountourakis P, Correa AM, Hofstetter WL, Lee JH, Bhutani MS, Rice DC, Komaki R, Maru DM, Ross WA, Vaporciyan A, Swisher SG, Ajani JA. Combined Modality Therapy of cT2N0M0 Esophageal Cancer: UT MD Anderson Cancer Center Experience. Cancer 117(5):925-30, 3/2011. e-Pub 10/2010.
55. Lee JH. Self-expandable metal stents for malignant distal biliary strictures. Gastrointest Endoscopy Clin N Am(21):463-480, 2011.
56. Welsh J, Amini A, Likhacheva A, Erasmus JJ, Gomez D, Davila M, Mehran RJ, Komaki R, Liao Z, Hofstetter WL, Lee JH, Bhutani MS, Ajani JA. Update: modern approaches to the treatment of localized esophageal cancer. Curr Oncol Rep 13(3):157-67, 2011.
57. Weston BR, Ross WA, Liu J, Lee JH. Clinical outcomes of nitinol and stainless steel uncovered metal stents for malignant biliary strictures. Is there a difference? Gastrointest Endosc 72(6):1195-200, 12/2010.
58. Lee JH, Ross WA, Davila R, Chang G, Lin E, Dekovich A, Davila M. Self-expandable metal stents (SEMS) can serve as a bridge to surgery or as a definitive therapy in patients with an advanced stage of cancer: Clinical experience of a tertiary cancer center. Dig Dis Sci 55(12):3530-6, 12/2010. e-Pub 8/2010.
59. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Lee JH, Bhutani MS, Dekovich A, Swisher SG, Ajani JA. The influence of High Body Mass Index on Prognosis of Patients with Esophageal Carcinoma Following Surgery as Primary Therapy. Cancer 116(24):5619-27, 12/2010.
60. Ross WA, Egwin CI, Wallace MJ, Wang M, Madoff D, Lee JH. Outcomes in Lymphoma patients with obstructive jaundice: a cancer center experience. Dig Dis and Sci 55(11):3271-7, 11/2010. e-Pub 7/2010.
61. Kim SM, Park YY, Park ES, Cho JY, Izzo JG, Zhang D, Kim SB, Lee JH, Bhutani MS, Swisher SG, Wu X, Coombes KR, Maru D, Wang KK, Buttar NS, Ajani JA, Lee JS. Prognostic Biomarkers for Esophageal Adenocarcinoma Identified by Analysis of Tumor Transcriptome. PLoS One 5(11), 11/2010.
62. Atiq M, Javle M, Dang S, Lee JH. Cholangiocarcinoma: an endoscopist's perspective. Expert Rev Gastroenterol Hepatol 4(5):601-11, 10/2010.
63. Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Watson TJ, Swisher SG, Members of the MD Anderson Esophageal Cancer Group (Ajani JA, Lee JH, et al.) and the University of Rochester School of Medicine and Dentistry Foregut Group. Endoscopic Esophageal Tumor Length: A Novel Prognostic Factor for Esophageal Cancer Patients. Cancer 252(4):611-7, 10/2010. e-Pub 8/2010.
64. Gu J, Ajani JA, Hawk ET, Ye Y, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Wang KK, Wu X. Genome-wide catalogue of chromosomal aberrations in Barrett's esophagus and esophageal adenocarcinoma: A high-density single nucleotide polymorphism array analysis. Cancer Prev Res (phila PA) 3(9):1176-86, 9/2010. e-Pub 8/2010.
65. Swisher SG, Hofstetter W, Komaki R, Correa AM, Erasmus J, Liao Z, Lee JH, Maru D, Mehran R, Patel S, Phan A, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, and Ajani JA. Improved Long-term outcome with chemoradiotherapy strategies in esophageal cancer. Ann Thorac Surg 90(3):892-8, 9/2010.
66. Kim MP, Correa AM, Lee JH, Rice DC, Roth JA, Mehran RJ, Walsh GL, Ajani JA, Maru DM, Chang JY, Marom EM, Macapinlac HA, Lee JH, Vaporciyan AA, Rice T, Swisher SG, Hofstetter WL. Pathologic T0N1 Esophageal Cancer After Neoadjuvant Therapy and Surgery: An Orphan Status. Ann Thorac Surg 90(3):884-89, 9/2010.
67. Murthy SB, Patnana SV, Xiao L, Rohren E, Hofstetter WL, Swisher SG, Liao Z, Lee JH, Bhutani MS, Macapinlac HA, Wang X, Ajani JA. The Standardized uptake value of 18-Fluoro-deoxy-glucose positron emission tomography after chemoradiation and clinical outcome in patients with localized gastroenterology carcinoma. Oncology 78 (5-6):316-322, 8/2010.
68. Katz MH, Varadhachar GR, Fleming JB, Wolff RA, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Sun CC, Wang H, Crane CH, Lee JH, Tamm EP, Abbruzzese JL, Evans DB. Serum CA19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradtion. Ann Surg Oncol 17(7):1794-801, 7/2010.
69. Das P, Jiang Y, Lee JH, Bhutani MS, Ross WA, Mansfield PF, Ajani JA. Multimodality approaches to localized gastric cancer. J Natl Compr Canc Netw 8(4):417-25, 4/2010.
70. Ajani JA, Correa AM, Walsh GL, Komaki R, Lee JH, Vaporciyan AA, Rice DC, Yao JC, Maru DM, Hofstetter WL, Phan AT, Swisher SG. Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction. Cancer 116(7):1656-63, 4/2010.
71. Weston BA, Iyer RB, Qiao W, Lee JH, Bresalier RS, Ross WA. Ability of Integrated Positron Emission and Computed Tomography to Detect Significant Colonic Pathology: The Experience of a Tertiary Cancer Center. Cancer 116(6):1454-61, 3/2010.
72. Patnana SV, Murthy SB, Xiao L, Rohren E, Hofstetter WL, Swisher SG, Liao Z, Lee JH, Bhutani MS, Macapinlac HA, Wang X, Ajani JA. Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography. Cancer 116(19):4487-94, 2010.
73. Javeri H, Xiao L, Rohren E, Lee JH, Liao Z, Hofstetter W, Maru D, Bhutani MS, Swisher SG, Macapinlac H, Wang X, and Ajani JA. Higher the Decrease in the Standardized Uptake Value of Positron Emission Tomography after Chemoradiation Better the Survival of Patients with Gastroesophageal Adenocarcinoma. Cancer 115(22):5184-92, 11/2009.
74. Bhutani MS, Verma D, Guha S, Lee JH, Richards-Kortum RR, Fleming JB. Is Endoscopic Ultrasound "Sound" for Pancreatic Cancer Screening? J Clin Gastroenterol 43(9):797-802, 10/2009. PMID: 19652621.
75. Leung KK, Ross WA, Evans D, Fleming J, Lin E, Tamm EP, Lee JH. Pancreatic cystic neoplasm: the role of cyst morphology, cyst fluid analysis, and expectant management. Ann Surg Oncol 16(10):2818-24, 10/2009. e-Pub 6/2009. PMID: 19536601.
76. Rice DC, Steliga MA, Stewart J, Eapen G, Jimenez C, Lee JH, Hofstetter W, Marom EM, Mehran R, Vaporicyan A, Walsh G, Swisher S. Endobronchial ultrasound guided needle biopsy for staging of malignant pleural mesothelioma. The Annals of Thoracic Surgery 88(3):862-8, 9/2009.
77. Lee JH, Stewart J, Ross WA, Anandasabapathy S, Xiao L, Staerkel G. Blinded Prospective Comparison of the Performance of 22-gauge and 25-gauge needles in Endoscopic Ultrasound-Guided Fine Needle Aspiration of the Pancreas and Peri-pancreatic lesions. Dig Dis Sci 54(10):2274-81, 8/2009.
78. Lagaly R, Horak A, Lee JH, Mansfield PF, Ajani JA. Patient with advanced gastric cancer responds twice to the same systemic therapy. Gastrointest Cancer Res 3(3):115-7, 3, 5/2009.
79. Javeri H, Xiao L, Rohren E, Komaki R, Hofstetter W, Lee JH, Maru D, Bhutani MS, Swisher SG, Wang X, Ajani JA. Influence of the baseline 18F-fluoro-2-deoxy-D-glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cancer undergoing chemoradiation. Cancer 115(3):624-630, 2/2009.
80. Cen P, Correa AM, Lee JH, Maru D, Anandasabapathy S, Liao Z, Hofstetter WL, Swisher SG, Komaki R, Ross WA, Vaporciyan A, Ajani JA. Adenocarcinoma of the lower esophagus with Barrett's esophagus or without Barrett's esophagus: differences in patients' survival after preoperative chemoradiation. Dis Esophagus 22(1):32-41, 2009.
81. Izzo JG, Wu X, Wu TT, Huan P, Lee JS, Liao Z, Lee JH, Bhutani MS, Hofstetter W, Maru D, Hung MC, Ajani JA. Therapy-induced Expression of NF-kB Portends Poor Prognosis in Patients with Localized Esophageal Cancer Undergoing Preoperative Chemoradiation. Dis Esophagus 22(2):127-32, 2009.
82. Ross WA and Lee JH. Endoscopic Approach to Tracheoesophageal Fistulas in Adults. Techniques in Gastrointestinal Endoscopy 10(4):155-163, 10/2008.
83. Ross WA, Wasan SM, Evans DB, Wolff RA, Trapani LV, Staerkel GA, Prindiville T, Lee JH. Combined endoscopic ultrasound with fine-needle aspiration and endoscopic retrograde cholangiopancreatography in the evaluation of patients presenting with obstructive jaundice from presumed pancreatic malignancy. Gastrointest Endosc 68(3):461-6, 9/2008.
84. Javeri H, Arora R, Correa AM, Hofstetter WL, Lee JH, Zhongzing L, McAleer MF, Maru D, Bhutani MS, Swisher SG, Izzo JG, Ajani, JA. Influence of Induction Chemotherapy and Class of Cytotoxics on Pathologic Response and Survival After Preoperative Chemoradiation in Patients with Carcinoma of the Esophagus. Cancer 113(6):1302-8, 15, 9/2008.
85. Katz MH, Mortenson MM, Wang H, Hwang R, Tamm EP, Staerkel G, Lee JH, Evans DB, Fleming JB. Diagnosis and management of cystic neoplasms of the pancreas: an evidence-based approach. J Am Coll Surg 207(1):106-20, 7/2008.
86. Varadhachary GR, Wolff RA, Crane CH, Sun CC, Tamm EP, Wang H, Lee JE, Pisters PWT, Vauthey JN, Abdalla E, Lee JH, Ho L, Staerkel GA, Bhosale PR, Ross WA, Krishnan S, Xiong H, Das P, Abbruzzese JL, Evans DB. Preoperative Gemcitabine and Cisplatin followed by Gemcitabine-based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head. J Clin Oncol 26(21):3487-95, 7/2008.
87. Hwang RF, Wang H, Lara A, Gomez H, Chang T, Sieffert N, Moon Y, Ram S, Zimmerman S, Lee JH, Pisters PW, Tamm EP, Fleming JB, Abbruzzese JL, Evans DB. Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer. Ann Surg Oncol 15(5):1356-66, 5/2008.
88. Cen P, Hofstetter WL, Correa AM, Wu TT, Lee JH, Ross WA, Davila M, Swisher SG, Fukami N, Rashid A, Maru D, Ajani JA. Lymphovascular Invasion as a Tool to Further Subclassify T1b Esophageal Adenocarcinoma. Cancer 112:1020-1027, 1/2008.
89. Ross WA, Ghosh S, Dekovich AA, Liu S, Ayers GD, Cleary KR, Lee JH, Couriel D. Endoscopic biopsy diagnosis of acute gastrointestinal graft-versus-host disease: rectosigmoid biopsies are more sensitive than upper gastrointestinal biopsies. Am J Gastroenterol 103(4):982-9, 2008.
90. Weston BR, Ross WA, Wolff RA, Evans D, Lee JE, Wang X, Xiao LC, Lee JH. Rate of bilirubin regression after stenting in malignant biliary obstruction for the initiation of chemotherapy: How soon should we repeat endoscopic retrograde cholangiopancreatography? Cancer 112(11):2417-23, 2008. PMID: 18404695.
91. Ajani, JA, Izzo J, Wang X, Chao C, Wu, TT, Malhotra, U, Vaporciyan AA, Lee JH, Bhutani M, Liao Z, Lee, JS, Wu, X, Berry D. Biomarker Signature that is highly predictive of pathologic complete response in patients with gastroesophageal adenocarcinoma undergoing preoperative chemoradiation. Journ of Clin Onc. Submitted.
92. Krishna S, Rao B, Lee JH, Ramireddy S, Guindani M, Ross WA. Safety, necessity of standard endoscopic interventions, and management of gastrointestinal bleeding in patients with thrombocytopenia. Amer Journ of Gastroenterol. Submitted.


1. Singh A, Lee JH. self-expanding metal stents for preoperative biliary drainage in patients receiving neoadjuvant therapy for pancreatic cancer. J Gastrointest Oncol 3(4):304-5, 12/2012. PMCID: PMC3492472.

Book Chapters

1. Bhosale P, Fleming J, Das P, Javle M, Lee JH. Cystic Pancreatic Lesions. In: Oncologic Imaging. Ed(s) Paul Silverman. Bermedica Production, Ltd. Columbia, MD, 1-19, 2012.
2. Tamm EP, Balachandran A, Bhosale PR, Katz MH, Fleming JB, Lee JH, Varadhachary GR. Imaging of Pancreatic Adenocarcinoma: Update on Staging/Resectability. In: Radiologic CLinics of North America. 50. Ed(s) Miller FM, Morgan DE, Mortele KJ. WB Saunders, 407-428, 2012.
3. Lee JH, Kelsey P. Choledochoscopy and Pancreatoscopy. In: Successful training in gastrointestinal endoscopy. Ed(s) Cohen J. Wiley-Blackwell: New York, 116-124, 2011.
4. Lee JH, Tamm EP. Pancreatic Carcinoma: Detection and Staging. In: EUS Pathology with Digital anatomy Correlation. People's Medical Publishing House: Shelton, CT, 149, 2010.
5. Javle M, Abernethy A, Busaidy NL, Lee JH. Dilemmas in upper gastrointestinal cancers, focus on symptom improvement. In: 2009 ASCO Educational Book, 2009.
6. Yendamuri S, Lee JH, Rice DC. Malignant: Metastatic. In: Esophageal Cancer Principles and Practice. Ed(s) Jobe BA, Thomas CR, Hunter JG. demosmedical, 355-359, 2009.
7. Lee JH, Ross WA. Invasive/Interventional Gastroenterology. In: Medical Care of Cancer Patients. Ed(s) Yeung SJ, Escalante C, Gagel R. BC Decker, 2008.
8. Lee, JH, Wolf J. Complications of IBD, 61. In: Osteopenia and Osteoporosis: Prevention and Treatment, Advanced Therapies in Inflammatory Bowel Disease, P289-292, 2000.

Last updated: 8/25/2015